Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.3490
+0.0270 (8.39%)
At close: Sep 30, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 9.05 million as of October 14, 2026. It is the 49,601st most valuable company in the world and the 803rd biggest in Sweden. Its market cap has decreased by 59.67% in one year.
Market Cap
9.05M
Enterprise Value
7.33M
Revenue
n/a
Global Rank
Country Rank
#803 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 9.05M, a decrease of -82.29%. That is a compound annual growth rate of -14.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.05M | -62.31% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 77.43M |
| Annexin Pharmaceuticals AB | 74.98M |
| AcouSort AB | 68.36M |
| Modus Therapeutics Holding AB | 56.06M |
| Fluicell AB | 38.05M |
| ExpreS2ion Biotech Holding AB | 25.65M |
| Magle Chemoswed Holding AB | 12.11M |
| Alligator Bioscience AB | 9.11M |